Breast Cancer

Ian E. Krop, MD, PhD, associate chief of the division of breast oncology in the Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute, spoke with Healio about a recent study on elacestrant.

In this video, Ian E. Krop, MD, PhD, associate chief of the division of breast oncology in the Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute, discusses results from the TROPION-PanTumor01 study.

Data from a study found that one in seven women in the U.S. will be overdiagnosed with breast cancer in their lifetimes.

The FDA cleared an investigational new drug application for P-MUC1C-ALLO1, a chimeric antigen receptor T-cell therapy designed to treat adults with locally advanced or metastatic epithelial-derived solid tumors.

A committee of experts from science, medicine and academia, among other fields, has recommended NASA proceed with a proposal for a universal, career-long radiation dose limit for all astronauts.

A select group of people who spend their day jobs fighting cancer — as surgical oncologists, radiation epidemiologists, or working in radiobiology and bionanotechnology — had a unique opportunity to lend their expertise to NASA.

In this video, Susan M. Domchek, MD, executive director of the Basser Center for BRCA and the director of the MacDonald Cancer Risk Evaluation Center at Penn Medicine, spoke with Healio about highlights from the San Antonia Breast Cancer Symposium.

Sara Tolaney, MD, MPH, spoke with Healio about results from the NIMBUS trial presented at San Antonio Breast Cancer Symposium 2021.

Use of dietary supplements appeared common among adults who had been diagnosed with cancer, many of whom believed the supplements could lower the risk for disease recurrence despite a lack of proven benefit, according to a study in Cancer.

Healio provided comprehensive coverage of this year’s San Antonio Breast Cancer Symposium.